Nudoxa Injection 50mg

Nudoxa 50mg Injection is an anticancer drug that features doxorubicin as its active ingredient, which is encapsulated within a closed lipid sphere known as a liposome.

Cancer is characterized by the uncontrolled and abnormal proliferation of cells. This medication is utilized in the treatment of breast cancer, ovarian cancer, multiple myeloma (a type of cancer affecting plasma cells, which are white blood cells), and Kaposi’s sarcoma associated with AIDS.

Individuals infected with HIV are at the highest risk for developing Kaposi’s sarcoma, a cancer that arises in the lining of lymphatic and blood vessels. Nudoxa 50mg Injection can be administered either on its own or in conjunction with other anticancer therapies. This medication is not advised for use in adolescents and children.

It is crucial to employ effective birth control methods during treatment and for at least six months following the final dose. Additionally, it is essential to inform your doctor if you have allergies to peanuts or soy, are undergoing treatment for heart or liver conditions, have diabetes, Kaposi’s sarcoma, or any oral health issues prior to receiving Nudoxa 50mg Injection.